US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
GB8311018D0
(en)
|
1983-04-22 |
1983-05-25 |
Amersham Int Plc |
Detecting mutations in dna
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5223427A
(en)
|
1987-03-31 |
1993-06-29 |
The Scripps Research Institute |
Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
|
US5217879A
(en)
|
1989-01-12 |
1993-06-08 |
Washington University |
Infectious Sindbis virus vectors
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
FR2650840B1
(fr)
|
1989-08-11 |
1991-11-29 |
Bertin & Cie |
Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
|
DK0452457T3
(da)
|
1989-11-03 |
1998-03-02 |
Univ Vanderbilt |
Fremgangsmåde til in vivo fjernelse af funktionelle fremmede gener
|
US5670488A
(en)
*
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
US5204253A
(en)
|
1990-05-29 |
1993-04-20 |
E. I. Du Pont De Nemours And Company |
Method and apparatus for introducing biological substances into living cells
|
US6770283B1
(en)
|
1990-12-13 |
2004-08-03 |
Bioption Ab |
DNA expression systems based on alphaviruses
|
US6004744A
(en)
|
1991-03-05 |
1999-12-21 |
Molecular Tool, Inc. |
Method for determining nucleotide identity through extension of immobilized primer
|
US6037135A
(en)
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
US9340577B2
(en)
|
1992-08-07 |
2016-05-17 |
Epimmune Inc. |
HLA binding motifs and peptides and their uses
|
US5662907A
(en)
|
1992-08-07 |
1997-09-02 |
Cytel Corporation |
Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
|
US20050271676A1
(en)
|
1993-03-05 |
2005-12-08 |
Epimmune Inc. |
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
|
DE69435171D1
(de)
|
1993-09-14 |
2009-01-08 |
Pharmexa Inc |
Pan dr-bindeproteinen zur erhöhung der immunantwort
|
US6413935B1
(en)
|
1993-09-14 |
2002-07-02 |
Epimmune Inc. |
Induction of immune response against desired determinants
|
ATE257176T1
(de)
|
1993-09-15 |
2004-01-15 |
Chiron Corp |
Rekombinanter alphavirus vektor
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
WO1995013392A1
(en)
|
1993-11-09 |
1995-05-18 |
Medical College Of Ohio |
Stable cell lines capable of expressing the adeno-associated virus replication gene
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
US5851806A
(en)
*
|
1994-06-10 |
1998-12-22 |
Genvec, Inc. |
Complementary adenoviral systems and cell lines
|
FR2726285B1
(fr)
|
1994-10-28 |
1996-11-29 |
Centre Nat Rech Scient |
Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
|
WO1996013597A2
(en)
|
1994-10-28 |
1996-05-09 |
The Trustees Of The University Of Pennsylvania |
Improved adenovirus and methods of use thereof
|
US5552350A
(en)
|
1994-12-12 |
1996-09-03 |
Ceramco Inc. |
Low-fusing temperature porcelain
|
AU709498B2
(en)
*
|
1994-12-12 |
1999-09-02 |
Genetic Therapy, Inc. |
Improved adenoviral vectors and producer cells
|
US5792462A
(en)
|
1995-05-23 |
1998-08-11 |
University Of North Carolina At Chapel Hill |
Alphavirus RNA replicon systems
|
US5851796A
(en)
*
|
1995-06-07 |
1998-12-22 |
Yale University |
Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes
|
UY24367A1
(es)
|
1995-11-23 |
2000-10-31 |
Boehringer Ingelheim Int |
Vacunas contra tumores y procedimiento para su produccion
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
EP0803573A1
(en)
|
1996-04-25 |
1997-10-29 |
Gesellschaft für Biotechnologische Forschung mbH (GBF) |
Polycistronic expression construct with cytokines for multivalent vaccines
|
US6514731B1
(en)
|
1996-05-24 |
2003-02-04 |
Chiron Corporation |
Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
|
WO1998000110A1
(en)
|
1996-07-03 |
1998-01-08 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
AU4255397A
(en)
|
1996-09-06 |
1998-03-26 |
Trustees Of The University Of Pennsylvania, The |
Chimpanzee adenovirus vectors
|
US5994132A
(en)
*
|
1996-10-23 |
1999-11-30 |
University Of Michigan |
Adenovirus vectors
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
US5849561A
(en)
|
1997-05-22 |
1998-12-15 |
Cornell Research Foundation, Inc. |
Method for the production of non-group C adenoviral vectors
|
PT974668E
(pt)
*
|
1998-07-07 |
2003-01-31 |
Transgene Sa |
Utilizacao de blocos de leitura da regiao e4 adenoviral para melhorar a expressao de um gene relevante
|
EP1000628A1
(en)
|
1998-09-28 |
2000-05-17 |
Fondation Mondiale Recherche et Prevention SIDA |
Use of antigenic complexes of HIV envelope and HLA class I antigens as HIV vaccine
|
US20030072767A1
(en)
|
1998-09-30 |
2003-04-17 |
Alexander Gaiger |
Compositions and methods for WT1 specific immunotherapy
|
US20080050393A1
(en)
|
1998-12-03 |
2008-02-28 |
Tang Y Tom |
Novel nucleic acids and polypeptides
|
WO2000034445A2
(en)
|
1998-12-07 |
2000-06-15 |
U.S. Medical Research Institute Of Infectious Diseases |
Live attenuated venezuelan equine encephalitis vaccine
|
EP1150708A2
(en)
|
1999-02-11 |
2001-11-07 |
Genzyme Corporation |
Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
|
US7262049B2
(en)
*
|
1999-03-16 |
2007-08-28 |
Dana-Farber Cancer Institute, Inc. |
Pseudotyped lentiviral vectors and uses thereof
|
ATE386127T1
(de)
|
1999-04-08 |
2008-03-15 |
Novartis Vaccines & Diagnostic |
Verbesserung der immunantwort als anwendung in impfstoff und gentherapie
|
WO2000061772A2
(en)
|
1999-04-14 |
2000-10-19 |
Chiron Corporation |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
US8647864B2
(en)
|
1999-04-14 |
2014-02-11 |
Novartis Ag |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
US6365394B1
(en)
|
1999-09-29 |
2002-04-02 |
The Trustees Of The University Of Pennsylvania |
Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
|
WO2001045728A2
(en)
|
1999-12-21 |
2001-06-28 |
Epimmune Inc. |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
US20040248113A1
(en)
|
1999-12-28 |
2004-12-09 |
Alessandro Sette |
Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
|
US7462354B2
(en)
|
1999-12-28 |
2008-12-09 |
Pharmexa Inc. |
Method and system for optimizing minigenes and peptides encoded thereby
|
EP1250351B1
(en)
|
2000-01-28 |
2005-11-30 |
Statens Serum Institut |
Methods to identify ctl epitopes of hiv
|
JP4776852B2
(ja)
|
2000-01-28 |
2011-09-21 |
アメリカ合衆国 |
癌抗原nyeso−1由来の新規mhcクラスii拘束t細胞エピトープ
|
US20010055596A1
(en)
|
2000-03-24 |
2001-12-27 |
Meagher Madeleine Joy |
Compositions and methods for therapy and diagnosis of colon cancer
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
US20040115625A1
(en)
|
2000-10-02 |
2004-06-17 |
Reinhard Ebner |
Cancer gene determination and therapeutic screening using signature gene sets
|
US6783939B2
(en)
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
US7820441B2
(en)
|
2000-09-25 |
2010-10-26 |
The Regents Of The University Of Michigan |
Production of viral vectors
|
US20020137081A1
(en)
|
2001-01-08 |
2002-09-26 |
Olga Bandman |
Genes differentially expressed in vascular tissue activation
|
US7557200B2
(en)
|
2001-02-01 |
2009-07-07 |
Johns Hopkins University |
Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation
|
CN1147587C
(zh)
*
|
2001-05-30 |
2004-04-28 |
方炳良 |
一种增强细胞特异性目的基因表达的方法
|
US20030232324A1
(en)
|
2001-05-31 |
2003-12-18 |
Chiron Corporation |
Chimeric alphavirus replicon particles
|
EP1399183B1
(en)
|
2001-05-31 |
2010-06-30 |
Novartis Vaccines and Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
ATE530672T1
(de)
|
2001-06-22 |
2011-11-15 |
Univ Pennsylvania |
Rekombinante adenoviren mit affen-adenovirus proteinen und verwendung davon.
|
BR0308783A
(pt)
|
2002-04-25 |
2005-01-04 |
Crucell Holland Bv |
Vetor de adenovìrus recombinante, método para produzir um vetor de adenovìrus recombinante, composição farmacêutica, método para tratar um corpo humano, e, kit de partes
|
WO2004001032A2
(en)
|
2002-04-25 |
2003-12-31 |
Crucell Holland B.V. |
Stable adenoviral vectors and methods for propagation thereof
|
WO2004023973A2
(en)
|
2002-09-12 |
2004-03-25 |
Incyte Corporation |
Molecules for diagnostics and therapeutics
|
EP1594447A2
(en)
|
2002-10-02 |
2005-11-16 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
KR20050083719A
(ko)
|
2002-10-03 |
2005-08-26 |
에피뮨 인코포레이티드 |
최적화된 멀티-에피토프 구성체 및 이의 용도
|
BRPI0317276B8
(pt)
|
2002-12-13 |
2021-05-25 |
Alphavax Inc |
método para a preparação de partículas de replicon de alfavírus (arps)
|
EP1585812B1
(en)
|
2002-12-13 |
2017-01-18 |
Alphavax, Inc. |
Multi-antigenic alphavirus replicon particles and methods
|
GB2398300A
(en)
|
2003-02-17 |
2004-08-18 |
Isis Innovation |
Method and compositions for boosting immune response
|
US7425328B2
(en)
|
2003-04-22 |
2008-09-16 |
Purdue Pharma L.P. |
Tissue factor antibodies and uses thereof
|
WO2005033265A2
(en)
|
2003-04-25 |
2005-04-14 |
Epimmune Inc. |
Optimized multi-epitope constructs and uses thereof
|
US7605235B2
(en)
|
2003-05-30 |
2009-10-20 |
Centocor, Inc. |
Anti-tissue factor antibodies and compositions
|
PT1629004E
(pt)
|
2003-06-05 |
2008-11-14 |
Wyeth Corp |
Composições imunogénicas compreendendo vectores do replicão do vírus da encefalite equina venezuelana e antigénios proteicos de paramixovírus
|
US7291498B2
(en)
|
2003-06-20 |
2007-11-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
DE602005017743D1
(de)
|
2004-01-23 |
2009-12-31 |
Angeletti P Ist Richerche Bio |
Impfstoffträger für schimpansen-adenovirus
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
US8394386B2
(en)
*
|
2004-04-28 |
2013-03-12 |
The Trustees Of The University Of Pennsylvania |
Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations
|
CA2563500C
(en)
*
|
2004-04-28 |
2016-06-28 |
The Trustees Of The University Of Pennsylvania |
Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost
|
ES2647491T3
(es)
|
2004-05-21 |
2017-12-21 |
Novartis Vaccines And Diagnostics, Inc. |
Vectores del alfavirus para las vacunas del virus de la gripe
|
PT1751290E
(pt)
|
2004-05-25 |
2015-02-03 |
Novartis Vaccines & Diagnostic |
Construções de empacotamento de replicão de alfa vírus
|
WO2006007712A1
(en)
|
2004-07-19 |
2006-01-26 |
Protiva Biotherapeutics, Inc. |
Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
|
AU2005290930B2
(en)
|
2004-10-04 |
2010-12-16 |
Biovaxim Limited |
Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection
|
US20060198854A1
(en)
|
2004-12-28 |
2006-09-07 |
Peter Pushko |
Vector platforms derived from the alphavirus vaccines
|
US7220549B2
(en)
|
2004-12-30 |
2007-05-22 |
Helicos Biosciences Corporation |
Stabilizing a nucleic acid for nucleic acid sequencing
|
FR2882557A1
(fr)
|
2005-02-25 |
2006-09-01 |
Centre Nat Rech Scient |
Epitopes de vih et composition pharmaceutique les contenant
|
US7283337B2
(en)
|
2005-03-04 |
2007-10-16 |
Headway Technologies, Inc. |
Abutted exchange bias design for sensor stabilization
|
US10000757B2
(en)
|
2005-05-27 |
2018-06-19 |
Ospedale San Raffaele S.R.L. |
Gene vector
|
EP2578685B1
(en)
|
2005-08-23 |
2019-04-17 |
The Trustees Of The University Of Pennsylvania |
Rna containing modified nucleosides and methods of use thereof
|
EP1945247A1
(en)
|
2005-10-18 |
2008-07-23 |
Novartis Vaccines and Diagnostics, Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
ZA200807544B
(en)
|
2006-02-27 |
2009-11-25 |
Univ Texas |
Pseudoinfectious flavivirus and uses thereof
|
AU2007296489B2
(en)
|
2006-09-12 |
2013-07-04 |
Alphavax, Inc. |
Alphavirus replicon particles matched to protein antigens as immunological adjuvants
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
GB0706914D0
(en)
|
2007-04-10 |
2007-05-16 |
Isis Innovation |
Novel adenovirus vectors
|
US8420779B2
(en)
|
2007-05-22 |
2013-04-16 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
EP2167137B1
(en)
|
2007-05-31 |
2013-10-16 |
GENimmune N.V. |
Hpv polyepitope constructs and uses thereof
|
PL2947149T3
(pl)
|
2007-06-21 |
2018-09-28 |
Alphavax, Inc. |
Kasety bez promotora do ekspresji alfawirusowych białek strukturalnych
|
US20100015179A1
(en)
|
2007-08-16 |
2010-01-21 |
Frolov Ilya V |
Attenuation of encephalitogenic alphavirus and uses thereof
|
WO2009034190A2
(en)
|
2007-09-14 |
2009-03-19 |
Genimmune N.V. |
Affinity tag
|
US20100285050A1
(en)
|
2007-10-05 |
2010-11-11 |
Isis Innovation Limited |
Compositions and Methods
|
GB0719526D0
(en)
|
2007-10-05 |
2007-11-14 |
Isis Innovation |
Compositions and methods
|
EP2225374B1
(en)
|
2007-11-26 |
2013-08-14 |
Novartis AG |
Methods of generating alphavirus particles
|
US20110091496A1
(en)
|
2008-01-19 |
2011-04-21 |
Graham Barney S |
Methods and compositions for the delivery of vaccines to disrupted epithelium
|
US20090253184A1
(en)
|
2008-01-23 |
2009-10-08 |
Introgen Therapeutics, Inc. |
Compositions and methods related to an adenoviral trans-complementing cell line
|
NZ603790A
(en)
|
2008-01-24 |
2014-08-29 |
Univ Texas |
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
|
WO2009120947A1
(en)
|
2008-03-28 |
2009-10-01 |
Virxsys Corporation |
Lentivirus-based immunogenic vectors
|
WO2009146902A1
(en)
|
2008-06-03 |
2009-12-10 |
Okairòs Ag |
A vaccine for the prevention and therapy of hcv infections
|
WO2010005704A2
(en)
|
2008-06-13 |
2010-01-14 |
New York University |
Novel helper plasmid, defective sindbis viral vectors and methods of use thereof
|
DK2310510T3
(en)
|
2008-07-17 |
2015-08-03 |
Medigen Inc |
IDNA vaccines and methods for their use
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
WO2010044515A1
(ko)
|
2008-10-17 |
2010-04-22 |
Lee Jeong-Min |
병뚜껑
|
US9353353B2
(en)
|
2008-11-26 |
2016-05-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Virus-like particles (VLPs) prepared from chikungunya virus structural proteins
|
EP2370584B1
(en)
|
2008-12-01 |
2014-11-05 |
Alphavax, Inc. |
Use of microRNAs to control virus helper nucleic acids
|
DE102008061522A1
(de)
|
2008-12-10 |
2010-06-17 |
Biontech Ag |
Verwendung von Flt3-Ligand zur Verstärkung von Immunreaktionen bei RNA-Immunisierung
|
CA3108979A1
(en)
*
|
2009-02-02 |
2010-08-05 |
Glaxosmithkline Biologicals Sa |
Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
|
CN101579528B
(zh)
|
2009-06-24 |
2011-06-29 |
中国人民解放军军事医学科学院军事兽医研究所 |
一种hiv复合多表位dna疫苗及其应用
|
GB0918154D0
(en)
|
2009-10-16 |
2009-12-02 |
Isis Innovation |
Mycobacterial vaccines
|
EP2519266B1
(en)
|
2009-12-31 |
2017-07-26 |
Medigen, Inc. |
Infectious dna vaccines against chikungunya virus
|
GB201006405D0
(en)
|
2010-04-16 |
2010-06-02 |
Isis Innovation |
Poxvirus expression system
|
EP3023788B1
(en)
|
2010-05-14 |
2020-02-12 |
The General Hospital Corporation |
Compositions of tumor specific neoantigens for use in treating tumours
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
CN106421773A
(zh)
|
2010-07-06 |
2017-02-22 |
诺华股份有限公司 |
自我复制rna分子的病毒样递送颗粒
|
CN108042799A
(zh)
|
2010-07-06 |
2018-05-18 |
诺华股份有限公司 |
阳离子水包油乳液
|
DK3243526T3
(da)
|
2010-07-06 |
2020-02-17 |
Glaxosmithkline Biologicals Sa |
Levering af rna til at udløse flere immunsignalveje
|
EP2590626B1
(en)
|
2010-07-06 |
2015-10-28 |
GlaxoSmithKline Biologicals SA |
Liposomes with lipids having an advantageous pka-value for rna delivery
|
CA3169291A1
(en)
|
2010-07-06 |
2012-01-12 |
Glaxosmithkline Biologicals Sa |
Immunisation of large mammals with low doses of rna
|
KR101667094B1
(ko)
*
|
2010-08-16 |
2016-10-17 |
더 솔크 인스티튜트 포 바이올로지칼 스터디즈 |
항암 아데노바이러스
|
CN103384515B
(zh)
|
2010-08-31 |
2017-02-15 |
诺华有限公司 |
适用于脂质体递送编码蛋白质的rna的脂质
|
HRP20221533T1
(hr)
|
2010-08-31 |
2023-02-17 |
Glaxosmithkline Biologicals Sa |
Pegilirani liposomi za isporuku rna koja kodira imunogen
|
SI4008357T1
(sl)
|
2010-08-31 |
2023-04-28 |
Glaxosmithkline Biologicals Sa |
Mali liposomi za dostavo imunogen-kodirajoče RNA
|
EP3225697A3
(en)
|
2010-12-30 |
2017-11-22 |
Foundation Medicine, Inc. |
Optimization of multigene analysis of tumor samples
|
US9487563B2
(en)
|
2011-01-31 |
2016-11-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Virus-like particles and methods of use
|
US8722044B2
(en)
|
2011-03-15 |
2014-05-13 |
Janssen Biotech, Inc. |
Human tissue factor antibody and uses thereof
|
US20140248314A1
(en)
|
2011-05-13 |
2014-09-04 |
Novartis Ag |
Pre-fusion rsv f antigens
|
ES2746233T3
(es)
|
2011-05-24 |
2020-03-05 |
Biontech Rna Pharmaceuticals Gmbh |
Vacunas individualizadas para el cáncer
|
GB201108879D0
(en)
|
2011-05-25 |
2011-07-06 |
Isis Innovation |
Vector
|
WO2012171541A1
(en)
|
2011-06-15 |
2012-12-20 |
Scil Proteins Gmbh |
Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins
|
EP2729165B1
(en)
|
2011-07-06 |
2017-11-08 |
GlaxoSmithKline Biologicals SA |
Immunogenic combination compositions and uses thereof
|
JP2014520806A
(ja)
|
2011-07-06 |
2014-08-25 |
ノバルティス アーゲー |
Rna分子の送達のための有用なn:p比を有するリポソーム
|
CA2841047A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic compositions and uses thereof
|
KR102067760B1
(ko)
|
2011-08-16 |
2020-01-17 |
삼성전자주식회사 |
세포 내 전달용 단백질 복합체 및 그의 용도
|
AU2012301715B2
(en)
|
2011-08-31 |
2017-08-24 |
Glaxosmithkline Biologicals S.A. |
Pegylated liposomes for delivery of immunogen-encoding RNA
|
RU2014118727A
(ru)
|
2011-10-11 |
2015-11-20 |
Новартис Аг |
Рекомбинантные самореплицирующиеся полицистронные молекулы рнк
|
SG11201404711WA
(en)
|
2012-02-16 |
2014-09-26 |
Vlp Therapeutics Llc |
Virus like particle composition
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US20160289674A1
(en)
|
2012-04-02 |
2016-10-06 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of membrane proteins
|
BR112014028684A2
(pt)
|
2012-05-18 |
2017-07-25 |
Univ Pennsylvania |
subfamília e adenovírus de símio a1302, a1320, a1331 e a1337 e usos dos mesmos
|
EP2870236B1
(en)
|
2012-07-04 |
2018-01-10 |
Sirion Biotech GmbH |
Means and methods to increase adenovirus production
|
JP2015522580A
(ja)
|
2012-07-06 |
2015-08-06 |
ノバルティス アーゲー |
免疫学的組成物およびその使用
|
US8961995B2
(en)
|
2012-09-20 |
2015-02-24 |
Uab Research Foundation |
Methods and compositions for alphavirus replicons
|
GB201220119D0
(en)
|
2012-11-08 |
2012-12-26 |
Univ Cork |
Vector
|
NZ708144A
(en)
*
|
2012-11-16 |
2020-03-27 |
Beth Israel Deaconess Medical Ct Inc |
Recombinant adenoviruses and use thereof
|
KR101429696B1
(ko)
*
|
2012-11-21 |
2014-08-13 |
국립암센터 |
안전성 및 항암활성이 증가된 재조합 아데노바이러스 및 이의 용도
|
US9402888B2
(en)
|
2013-03-14 |
2016-08-02 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for treating cancer
|
EP2983702A2
(en)
|
2013-04-07 |
2016-02-17 |
The Broad Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
BR112015030229B1
(pt)
|
2013-06-03 |
2023-04-18 |
VLP Therapeutics, Inc |
Partícula semelhante a vírus compreendendo um polipeptídeo e um antígeno da malária, vetor, composições farmacêutica e de vacina, bem como molécula de ácido nucleico isolado
|
AU2014343321B2
(en)
|
2013-11-01 |
2020-02-06 |
Pfizer Inc. |
Vectors for expression of prostate-associated antigens
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
WO2015085233A1
(en)
|
2013-12-06 |
2015-06-11 |
The Broad Institute Inc. |
Formulations for neoplasia vaccines
|
CN106456724A
(zh)
|
2013-12-20 |
2017-02-22 |
博德研究所 |
使用新抗原疫苗的联合疗法
|
BR112017004202A2
(pt)
|
2014-09-03 |
2019-09-03 |
Bavarian Nordic As |
composições para intensificar respostas imunes e seus usos
|
EP4286407A3
(en)
|
2014-11-26 |
2024-03-06 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Anti-mutated kras t cell receptors
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
WO2016100977A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Methods for profiling the t-cel- receptor repertoire
|
WO2016122414A1
(en)
|
2015-01-29 |
2016-08-04 |
Agency For Science, Technology And Research |
Nanocapsules carrying chikungunya-associated peptides
|
DK3253795T3
(da)
|
2015-02-06 |
2019-07-29 |
Navigo Proteins Gmbh |
Hidtil ukendte bindende proteiner, der omfatter et ubiquitin-mutein, og antistoffer eller antistoffragmenter
|
WO2016154047A2
(en)
|
2015-03-20 |
2016-09-29 |
Memorial Sloan-Kettering Cancer Center |
Monoclonal antigen-binding proteins to intracellular oncogene products
|
EP3286222A4
(en)
|
2015-03-23 |
2018-08-08 |
The Johns Hopkins University |
Hla-restricted epitopes encoded by somatically mutated genes
|
EP3297660A2
(en)
|
2015-05-20 |
2018-03-28 |
The Broad Institute Inc. |
Shared neoantigens
|
CN116590285A
(zh)
|
2015-09-21 |
2023-08-15 |
垂林克生物技术有限公司 |
用于合成5’-加帽rna的组合物和方法
|
JP2018530579A
(ja)
|
2015-10-12 |
2018-10-18 |
ナントミクス,エルエルシー |
ウイルス性癌ネオエピトープのための組成物および方法
|
MX2018007204A
(es)
|
2015-12-16 |
2018-12-11 |
Gritstone Oncology Inc |
Identificacion, fabricacion y uso de neoantigeno.
|
MX2018010362A
(es)
|
2016-02-29 |
2019-03-28 |
Found Medicine Inc |
Metodos y sistemas para evaluar carga mutacional de tumores.
|
AU2017225787B2
(en)
|
2016-03-03 |
2021-09-23 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
KR20180129899A
(ko)
|
2016-03-31 |
2018-12-05 |
네온 테라퓨틱스, 인크. |
신생항원 및 이것의 사용 방법
|
WO2017184590A1
(en)
|
2016-04-18 |
2017-10-26 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
EP3452082A1
(en)
|
2016-05-04 |
2019-03-13 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
WO2017208191A1
(en)
|
2016-06-02 |
2017-12-07 |
Glaxosmithkline Biologicals Sa |
Zika viral antigen constructs
|
US10702598B2
(en)
|
2016-06-20 |
2020-07-07 |
Isa Pharmaceuticals B.V. |
Formulation of a peptide vaccine
|
GB2549809C
(en)
*
|
2016-06-23 |
2022-11-30 |
Univ Oxford Innovation Ltd |
Vector
|
CN107698593A
(zh)
|
2016-08-09 |
2018-02-16 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
US20210284733A1
(en)
|
2016-08-22 |
2021-09-16 |
Arbutus Biopharma Corporation |
Anti-pd-1 antibodies, or fragments thereof, for treating hepatitis b
|
MX2019006010A
(es)
*
|
2016-11-23 |
2019-12-05 |
Gritstone Oncology Inc |
Administracion viral de neoantigenos.
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
CN110036020A
(zh)
*
|
2016-12-09 |
2019-07-19 |
葛兰素史密丝克莱恩生物有限公司 |
具有狂犬病病毒抗原的黑猩猩腺病毒构建体
|
GB201620968D0
(en)
*
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
GB201621732D0
(en)
|
2016-12-20 |
2017-02-01 |
Agricultural Research Council |
A multi-epitope dna vaccine for heartwater
|
CA3047326A1
(en)
|
2016-12-21 |
2018-06-28 |
Arbutus Biopharma Corporation |
Methods for ameliorating infusion reactions
|
CN108064305B
(zh)
*
|
2017-03-24 |
2021-10-08 |
清华大学 |
可编程的溶瘤病毒疫苗系统及其应用
|
US20230241207A1
(en)
|
2017-04-03 |
2023-08-03 |
Neon Therapeutics, Inc. |
Protein antigens and uses thereof
|
US11504421B2
(en)
|
2017-05-08 |
2022-11-22 |
Gritstone Bio, Inc. |
Alphavirus neoantigen vectors
|
CA3066635A1
(en)
|
2017-06-09 |
2018-12-13 |
Gritstone Oncology, Inc. |
Neoantigen identification, manufacture, and use
|
TW201919653A
(zh)
|
2017-06-16 |
2019-06-01 |
加拿大商艾爾布圖斯生技公司 |
用於治療b型肝炎之治療組合物及方法
|
TWI823859B
(zh)
|
2017-07-21 |
2023-12-01 |
美商建南德克公司 |
癌症之治療及診斷方法
|
BR112020002555A2
(pt)
|
2017-08-07 |
2020-08-11 |
The Johns Hopkins University |
métodos e materiais para avaliar e tratar câncer
|
JP7421474B2
(ja)
|
2017-11-03 |
2024-01-24 |
ガーダント ヘルス, インコーポレイテッド |
腫瘍遺伝子変異量の正規化
|
WO2019170773A1
(en)
|
2018-03-06 |
2019-09-12 |
Cancer Research Technology Limited |
Improvements in variant detection
|
JP2021524247A
(ja)
|
2018-05-23 |
2021-09-13 |
グリットストーン バイオ インコーポレイテッド |
免疫チェックポイント阻害剤の共発現ベクター
|
KR20210013105A
(ko)
|
2018-05-23 |
2021-02-03 |
그릿스톤 온콜로지, 인코포레이티드 |
공유 항원
|
CN112912507A
(zh)
|
2018-11-07 |
2021-06-04 |
磨石肿瘤生物技术公司 |
甲病毒新抗原载体和干扰素抑制剂
|
CA3145833A1
(en)
|
2019-07-02 |
2021-01-07 |
Roman YELENSKY |
Hiv antigens and mhc complexes
|
WO2021092095A1
(en)
|
2019-11-04 |
2021-05-14 |
Gritstone Oncology, Inc. |
Neoantigen vaccine therapy
|
WO2021119545A1
(en)
|
2019-12-11 |
2021-06-17 |
Gritstone Bio, Inc. |
Durable vaccination
|
EP4087940A4
(en)
|
2020-01-10 |
2024-04-10 |
Gritstone Bio Inc |
CELLULAR DNA MONITORING
|
AU2021258191A1
(en)
|
2020-04-21 |
2022-12-01 |
Gritstone Bio, Inc. |
Antigen-encoding cassettes
|
IL300026A
(en)
|
2020-08-06 |
2023-03-01 |
Gritstone Bio Inc |
Multiepitope vaccine cassettes
|